Depression in general practice: a comparison of flupenthixol dihydrochloride and dothiepin hydrochloride.
A single-blind, parallel group, general practice study was carried out in 153 patients with mild to moderate depression to compare the efficacy and tolerability of flupenthixol dihydrochloride and dothiepin hydrochloride. Patients were allocated at random to receive single daily doses of either 1 mg flupenthixol in the morning or 75 mg dothiepin in the evening, and this dose could be doubled at the end of 2 weeks in the event of inadequate response. Assessments were made on entry and after 1, 2, 4 and 6 weeks of treatment using the Hamilton Depression Rating Scale, a 4-point severity scale and an unwanted symptoms checklist. The results showed that both treatments significantly improved the patients' condition over 6 weeks, and there was a significant difference in favour of flupenthixol at end-point. Both drugs were well tolerated, although persistence of anticholinergic side-effects in the dothiepin group resulted in a trend favouring flupenthixol. One patient in the flupenthixol group attempted suicide by overdose but made a complete recovery.
Dwivedi
V S
VS
Berger
A B
AB
Khong
T K
TK
Hamilton
B A
BA
Jones
P G
PG
Brantingham
P
P
Grillage
M G
MG
Prasad
S
S
Kundu
B N
BN
Renwick
J A
JA
D000293:Adolescent; D000328:Adult; D000368:Aged; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy*; D004308:Dothiepin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005194:Family Practice; D005260:Female; D005475:Flupenthixol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged
D005475:Flupenthixol; D004308:Dothiepin